Overview
Jon is an experienced litigator in complex civil litigation spanning commercial, antitrust, administrative, consumer protection, trade secrets, products liability, class actions and appeals.
He has represented and counseled clients in a wide range of industries, with a particular interest in pharmaceuticals and life sciences. Jon has extensive experience with federal and state antitrust and consumer protection issues, including those at the intersection of antitrust, intellectual property and trade secrets.
Jon routinely provides clients with strategic counseling regarding business, antitrust, regulatory, and consumer protection issues to navigate issues before they develop into potential liabilities or litigation. Clients commend Jon’s ability to conceive novel solutions to intractable problems and to see around corners to strategic issues on the horizon.
He has been recognized by The Legal 500 United States in the category of Dispute Resolution: Appellate.
In addition to his client-focused work, Jon maintains an active pro bono practice with a significant focus on voting rights litigation and representing unaccompanied immigrant children.
- District of Columbia
- Connecticut
- New York
- US Supreme Court
- US Court of Appeals, First Circuit
- US Court of Appeals, Second Circuit
- US Court of Appeals, Third Circuit
- US Court of Appeals, Fourth Circuit
- US Court of Appeals, Fifth Circuit
- US Court of Appeals, Sixth Circuit
- US Court of Appeals, Ninth Circuit
- US Court of Appeals, Tenth Circuit
- US Court of Appeals, District of Columbia Circuit
- US District Court, District of Connecticut
- US District Court, District of Columbia
- US District Court, District of Maryland
- US District Court, Southern District of New York
- Hon. Julia Smith Gibbons, US Court of Appeals for the Sixth Circuit
- Hon. Judge Alan Kay, U.S.M.J., US District Court for the District of Columbia
- J.D., The George Washington University Law School, 2008, with highest honors, Order of the Coif, Production Editor, The George Washington Law Review
- B.A., University of Maryland, 2002, magna cum laude
Representative Matters
- Lead counsel for generic pharmaceutical manufacturer plaintiff in antitrust litigation against brand manufacturer and supplier alleging anticompetitive scheme to lock up supply of the active pharmaceutical ingredient (API) for medication related to cardiovascular health and impede generic competitors.
- Lead counsel for generic pharmaceutical manufacturer defending nationwide antitrust class action brought by direct and indirect purchasers hypertension medication challenging the so-called "reverse payment" settlement of Hatch-Waxman patent litigation.
- Lead counsel for large national grocery and pharmacy chain defending multiple pharmaceutical products liability class actions and dozens of individual cases in a multi-district litigation (MDL) alleging personal injuries and economic losses purportedly due to nitrosamine contamination of blood pressure and hypertension medications.
- Lead counsel for generic pharmaceutical manufacturer defending complex trade secrets and breach of contract litigation concerning microsphere injectable products.
- Lead counsel for several generic pharmaceutical manufacturer plaintiffs in antitrust litigation against competitor alleging anticompetitive scheme to foreclose available supply of the active pharmaceutical ingredient (API) for medication related to female infertility and impede generic competition.
- Lead counsel for international dietary supplements manufacturer in product advertising disputes before the National Advertising Division (NAD) of the Better Business Bureau (BBB).
- Providing ongoing antitrust counseling and representation to various different pharmaceutical manufacturers regarding business decision making relating to contracting, business arrangements, and litigation.
- Counseling international medical device manufacturer in connection with U.S. regulatory and commercial compliance.
- Lead counsel for generic pharmaceutical manufacturer defending nationwide antitrust class action brought by direct and indirect purchasers of antidepressant medication challenging the so-called "reverse payment" settlement of Hatch-Waxman patent litigation.
- Lead counsel for generic pharmaceutical manufacturer defending nationwide antitrust class action brought by direct and indirect purchasers of blockbuster cholesterol medication challenging the so-called "reverse payment" settlement of Hatch-Waxman patent litigation.
- Counsel for the pharmaceutical trade association in successful constitutional challenge to Maryland state drug pricing law. Maryland law against price-gouging by drug companies is unconstitutional, appeals court rules, The Baltimore Sun, April 13, 2018.
- Counsel for the pharmaceutical trade association in constitutional challenge to New York state drug pricing law.
- Counsel for multiple generic pharmaceutical manufacturers in various suits defending nationwide several antitrust class actions brought by direct and indirect purchasers of other drug products challenging the so-called "reverse payment" settlement of Hatch-Waxman patent litigation.
- Counsel for Securities Investor Protection Corporation (SIPC) in first-ever action brought against it by the SEC in federal court in the District of Columbia. SEC Loses Bid to Get SIPC to Pay Stanford Ponzi Claims, The Wall Street Journal, July 3, 2012.
- Counsel for major financial institution in litigation relating to the Chapter 11 reorganization of its subsidiary relating to residential mortgages.
- Counsel for owner and operator of an extensive portfolio of extended-stay and select-service hotels, in a contested matter arising from its Chapter 11 reorganization.
- Counsel for major communications company in post-confirmation bankruptcy litigation.
News & Publications
Press Releases
February 24, 2026
Professional Affiliations
- American Bar Association